Professional Documents
Culture Documents
Sharing Knowledge To Uncover Cancer Cells Secret Disguises
Sharing Knowledge To Uncover Cancer Cells Secret Disguises
Sharing Knowledge To Uncover Cancer Cells Secret Disguises
disguises
elsevier.com/connect/archive/sharing-knowledge-to-uncover-cancer-cells-secret-disguises
How we used epigenetics to map the switches that help uterine cancer cells hide and
spread
Elsevier Connect
Endometrial cancer is the third leading cause of cancer-related deaths in women, with
75,000 deaths in 2012. But a disproportionate number of these deaths are due to a
particular, rare subtype: carcinosarcoma.
Most tumors are made up of cells that largely stick to a single pattern of growth, however
abnormal that pattern may be. But in a uterine carcinosarcoma (UCS), cells suffer from an
“identity crisis” – they switch off certain genes specific to the tissue they came from,
helping them fit in more easily in different tissues, spreading the cancer. Within a single
tumor, one can find several different cell types, and even elements that would never occur
on their own within the uterus.
We wanted to understand why these tumor cells are so good at spreading to other parts
of the body, and how we could stop that from happening and reduce the number of
deaths from endometrial cancer. We hypothesized that the ability of these cells to adopt
1/4
different guises may explain why they can spread so readily to different sites of the body.
In our study in Neoplasia, we created a map showing which genes were switched on and
off in different parts of the tumor to create the cells’ disguises, providing a “signature” of
these switches throughout the genome. Switching these genes back on could lead to
effective treatments in the future.
What we learned was that this was much harder to study than we expected.
Carcinosarcoma always consists of multiple components, and we wanted to study these
separately. To determine how these cells manage to switch from one type to another, we
started from three human UCS samples, which we microdissected into their two
component parts: carcinoma and sarcoma. This required us to learn to work with very
small amounts of material, and to find creative ways to use large public databases to
validate our findings.
While others had studied the genetic mutations in these tumors, we were interested in
studying epimutations – changes in the way the DNA is decorated that can turn genes on
or off. In the past, epigenetic changes were difficult to study on a genome-wide basis. Our
laboratory has pioneered several methods that make it possible to construct whole-
genome methylation maps at single-nucleotide resolution. With these improved tools, we
can now reveal epigenetic changes in cancers, which may well be just as significant as
genetic mutations.
We learned that some regions of the DNA are consistently hypermethylated (have more
decorations) in UCS, and other regions are consistently hypomethylated (have fewer
decorations). These changes switched off some tumor suppressor genes (KLF4, NDN,
and WT1), giving us potential targets to switch back on and suppress tumor growth.
2/4
Researchers have their own ways of managing and explaining the data they collect, and if
that information is hidden away in a lab book, it’s unlikely to be useful to anyone else.
That’s particularly unfortunate if the researcher changes institutions, leaving no usable
record of their work. In 2016, Elsevier acquired Hivebench – a lab notebook tool that puts
the essential first step in research data management at the researcher’s fingertips.
We also needed access to previously published research, which we got through the
Bernard Becker Medical Library at our institution; we could not have done this work
without consulting the literature. The library’s 3,700 journal subscriptions made it possible
for us to do this work at Washington University in St. Louis.
But we’re aware that not every university can support such a rich library. We therefore
chose an open-access model for publishing in Neoplasia to maximize the impact of our
work. Open access is a wonderful way to lower barriers to scientific communication, when
coupled with robust editorial standards and peer review.
Having the article on ScienceDirect is important to us because it’s a durable and visible
repository. We can count on ScienceDirect to provide high-quality content, carefully
edited, with correct standards of proofreading and publishing.
Neoplasia publishes the results of novel investigations in all areas of oncology research.
The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the
traditional disciplines of cancer research as well as emerging fields and interdisciplinary
investigations. Neoplasia is interested in studies describing new molecular and genetic
3/4
findings relating to the neoplastic phenotype and in laboratory and clinical studies
demonstrating creative applications of advances in the basic sciences to risk assessment,
prognostic indications, detection, diagnosis, and treatment. Read more.
4/4